| Abstrakt: |
Summary: Pharmaceutical Economics and Policy provides comprehensive discussions on a wide range of pharmaceutical economics and policy issues. This third edition re-examines ongoing issues such as industrial organization, R&D and innovation, competition and pricing, intellectual property and regulation. It also includes a number of new topics, such as the nascent biosimilar sector, globalization of supply chain, value-based pricing, evolving reimbursement landscape, and the emerging pharmaceutical market in large, developing economies such as China and India. |
